References:
- Bozkurt B, Kamat I, Hotez PJ. Myocarditis with COVID-19 mRNA Vaccines.
Circulation 2021; 144(6): 471-484
- Gang LV, Yuan J, Xiong X, et al. Mortality rate and characteristics of
deaths following COVID-19 vaccination. Front Med (Lausanne) 2021;
8670370
- Su JR, McNeil MM, Welsh KJ, et al. Myopericarditis after vaccination,
Vaccine Adverse Event Reporting System (VAERS), 1990–2018.Vaccine
2021; 39:839–845.
- Barth C, Mahfoud F, Ukena C,et al. Update on myocarditis. J Am Coll
Cardiol 2012;59: 779-792.
- Marshall M, Ferguson ID, Lewis P, et al. Symptomatic acute myocarditis
in seven adolescents following Pfizer-BioNTech COVID-19 vaccination.
Pediatrics 2021;2
- Graham BS. Rapid COVID-19 vaccine development.Science 2020;
368:945–946.
- Friedrich MG, Sechtem U, Schulz-Menger J, et al. Cardiovascular
magnetic resonance in myocarditis: A JACC White Paper. J Am Coll
Cardiol 2009;53(17): 1475–1487.
- Uziębło-Życzkowska B, Krzesiński P, et al. Cushing’s disease:
subclinical left ventricular systolic and diastolic dysfunction
revealed by speckle tracking echocardiography and tissue Doppler
imaging. Front Endocrinol (Lausanne) 2017; 8:1–8.
- Erley J, Genovese D, Tapaskar N, et al. Echocardiography and
cardiovascular magnetic resonance based evaluation of myocardial
strain and relationship with late gadolinium enhancement. J Cardiovasc
Magn Reson 2019; 21(1):46
- Uziębło-Życzkowska B, Mielniczuk M, Ryczek R, et al. Myocarditis
successfully diagnosed and controlled with speckle tracking
echocardiography. Cardiovasc Ultrasound 2020;18(1):19